Evotec SE EVT-DE:XETRA

*Data is delayed | EUR
Last | 04/22/21 CEST
34.08UNCH (UNCH)
52 week range
21.31 - 43.00

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close34.08
  • 52 Week High43.00
  • 52 Week High Date01/27/21
  • 52 Week Low21.31
  • 52 Week Low Date08/14/20

Key Stats

  • Market Cap6,593.69M
  • Shares Out163.66M
  • 10 Day Average Volume453,280.45
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change12.55

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close34.08
  • 52 Week High43.00
  • 52 Week High Date01/27/21
  • 52 Week Low21.31
  • 52 Week Low Date08/14/20
  • Market Cap6,593.69M
  • Shares Out163.66M
  • 10 Day Average Volume453,280.45
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change12.55

RATIOS/PROFITABILITY

  • EPS (TTM)0.03
  • P/E (TTM)1,136.00
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug...
Werner Lanthaler Ph.D.
Chief Executive Officer
Craig Johnstone
Chief Operating Officer
Enno Spillner
Chief Financial Officer
Address
Essener Bogen 7
Hamburg
22419
Germany